Literature DB >> 3180547

HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks.

J Zervas1, G Vayopoulos, N Sakellaropoulos, P Kaklamanis, P Fessas.   

Abstract

The distribution frequency of HLA-A and B antigens was determined in 24 Greek individuals with Adamantiades-Behçet's disease (A-BD) as well as in 280 controls. The standard NIH technique was used for tissue typing. There was an increased incidence of HLA-B5 in the patients group (75% compared to controls 32%). The calculated P corrected value was Pc less than 0.02, the relative risk (RR) was 6.23 and the aetiological fraction (EF) 0.68. This study agrees with the reported association between A-BD and HLA-B5 in other populations from the Mediterranean basin, the Middle East and Far East.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180547

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  10 in total

Review 1.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

2.  Primary association of HLA-B51 with Behçet's disease in Ireland.

Authors:  D J Kilmartin; A Finch; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

3.  HLA and Behçet's disease in northern Spain: their lack of correlation with arthritis pattern.

Authors:  J Sanchez Burson; J Graña Gil; M Rosales Rodriguez; A Atanes Sandoval; C Alonso Blanco; F Galdo Fernandez
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

4.  Adamantiadis-Behçet's disease in sisters.

Authors:  G Vaiopoulos; P P Sfikakis; P Hatzinikolaou; G Stamatelos; P Kaklamanis
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

5.  Neuro-Behçet: clinical features and MRI correlates.

Authors:  F Federico; M G Damiani; R De Blasi; M De Mari; P Lamberti; P Lattanzi; A Carella
Journal:  Ital J Neurol Sci       Date:  1993-01

Review 6.  Neonatal Behçet's disease without maternal history.

Authors:  Yung-Sen Chang; Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2011-08-26       Impact factor: 2.980

Review 7.  Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations.

Authors:  Violetta D Kapsimali; Meletios A Kanakis; George A Vaiopoulos; Phaedon G Kaklamanis
Journal:  Clin Rheumatol       Date:  2010-05-22       Impact factor: 2.980

Review 8.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

9.  Histopathological Evaluation of Behçet's Disease and Identification of New Skin Lesions.

Authors:  Ozgür Gündüz
Journal:  Patholog Res Int       Date:  2011-10-18

10.  Serum anti-Saccharomyces cerevisiae antibodies in Greek patients with Behcet's disease.

Authors:  George Vaiopoulos; Peter Laszlo Lakatos; Maria Papp; Faedon Kaklamanis; Efrosyni Economou; Vassilis Zevgolis; John Sourdis; Kostas Konstantopoulos
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.